Balanced news tone
News Sentiment
4502 sentiment intelligence
Takeda Pharmaceutical Company Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
54
Balanced news tone
20 relevant articles
News tone and price action are not far from neutral.
84/100 classification confidence.
directly relevant articles
high-authority source matches
+3.2% over one week, -3.7% over four weeks, trend inactive, and near fair-value range.
Takeda Stock - analyst focus on pipeline and earnings outlook
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
84/100 classification
One-week reaction
3.2%
Price confirming higher
Trend fit
Trend inactive
-3.7% over four weeks
Fair value
21.0%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
6
Neutral
12
Negative
2
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
AD HOC NEWS
Direct company coverage
Takeda Stock - analyst focus on pipeline and earnings outlook
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 17 Jun 2026 19:04
- Source
- AD HOC NEWS
GuruFocus
Direct company coverage
Takeda Pharmaceutical Co Ltd (TSE:4502) Stock Price, Trades & News
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 05:49
- Source
- GuruFocus
AD HOC NEWS
Direct company coverage
Takeda Pharmaceutical stock (JP3730800003): oncology focus meets pricing headwinds
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 20:42
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Takeda Pharmaceutical (ADR) stock (US8740602052): shares fall in New York after shelf registration u
- Tone
- Negative 22/100
- Event
- Market update
- Published
- 01 Jun 2026 23:02
- Source
- AD HOC NEWS
Stock Titan
Direct company coverage
Takeda (NYSE: TAK) files JPY 240B Japan shelf to support LTIP shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Stock Titan
AD HOC NEWS
Direct company coverage
Takeda Pharmaceutical stock (JP3730800003): Japan sales and U.S. exposure stay in focus
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Takeda Pharmaceutical stock (JP3730800003): oncology and rare disease focus after latest earnings up
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 May 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Takeda Pharmaceutical stock (JP3730800003): earnings in focus as investors weigh legal risks
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 19 May 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Takeda Pharmaceutical Co Ltd stock (JP3730800003): earnings beat but softer EPS outlook
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 16 May 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Takeda Pharmaceutical stock (JP3730800003): recent earnings and Rybelsus biosimilar plans in focus
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 May 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Takeda Pharmaceutical stock (JP3730800003): FY2026 profit surges 77.7%, but FY2027 guidance signals
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- AD HOC NEWS
Morningstar
Direct company coverage
Takeda Ready to Resume Top-Line Growth With Refreshed Late-Stage Pipeline
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 14 May 2026 07:00
- Source
- Morningstar
AD HOC NEWS
Direct company coverage
Takeda Pharmaceutical stock (JP3730800003): Q4 2026 earnings report released
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 May 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Takeda Pharmaceutical Co Ltd stock (JP3730800003): Japan’s largest pharma firm with strong US expo
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 08 May 2026 07:00
- Source
- AD HOC NEWS
Market source
Direct company coverage
Is Takeda Pharmaceutical Company Limited (TAK) One of the Best Japanese Stocks Amid Restructuring Drive?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 May 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
Takeda (NYSE: TAK) Japan Pharma chief details shares, RSUs and tax awards
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Mar 2026 07:00
- Source
- Stock Titan
Market source
Direct company coverage
Is Takeda Pharmaceutical Company Limited (TAK) One of the Best Healthcare Stocks to Buy for 2026?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 31 Jan 2026 08:00
- Source
- Market source
Gotrade
Direct company coverage
Takeda Pharmaceutical (TAK) Stock Price Today & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Dec 2025 20:17
- Source
- Gotrade
Seeking Alpha
Direct company coverage
Takeda: Lack Of Realistic Upside In Japanese Pharma (NYSE:TAK)
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 11 Dec 2025 08:00
- Source
- Seeking Alpha
Reuters
Direct company coverage
Japan's Takeda weighs India for global trials to speed up drug launches
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Aug 2025 07:00
- Source
- Reuters